Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients
Table 1
Pharmacokinetic parameters for belinostat after 30 min i.v. infusion in Phase I trial.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Pharmacokinetic parameters for belinostat after 30 min i.v. infusion in Phase I trial.